Raid: Shadow Legends developer Plarium has been acquired by Modern Times Group for an eye-watering $620 million. Yes, you ...

A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

MORRISVILLE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that ...

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data expected by early 2025 Completed Phase ...